Dr Reddy’s to launch generic Ozempic in India from March
Dr Reddy’s launch of generic Ozempic, used to treat type-2 diabetes, marks the onset of an influx of global competition that Novo Nordisk is expecting for its $30 billion franchise
Dr Reddy’s launch of generic Ozempic, used to treat type-2 diabetes, marks the onset of an influx of global competition that Novo Nordisk is expecting for its $30 billion franchise
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
